Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1393 | 1110 | 1592 | 1973 | 3851 | 4242 |
Fund Return | 39.26% | 11% | 59.2% | 25.42% | 30.95% | 15.55% |
Place in category | 28 | 9 | 40 | 2 | 11 | 8 |
% in Category | 29 | 9 | 42 | 2 | 18 | 34 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
SBI Magnum Balanced Fund Direct Div | 715.85B | 14.52 | 11.32 | 13.24 | ||
SBI Magnum Balanced Fund Direct Gro | 715.85B | 14.52 | 11.32 | 13.32 | ||
SBI Magnum Balanced Fund Regular Gr | 715.85B | 13.87 | 10.55 | 12.37 | ||
SBI Magnum Balanced Reg Div Payout | 715.85B | 13.87 | 10.55 | 12.29 | ||
SBI Bluechip Fund Regular Dividend | 504.47B | 14.89 | 13.14 | 13.33 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Reliance Pharma Direct Bonus | 86.89B | 31.89 | 20.92 | 16.54 | ||
Reliance Pharma Direct Growth | 86.89B | 31.89 | 20.92 | 16.54 | ||
Reliance Pharma Dir Div Payout | 86.89B | 31.34 | 22.08 | 17.31 | ||
Reliance Pharma Fund - Bonus | 86.89B | 30.90 | 19.84 | 15.52 | ||
Reliance Pharma Dividend Payout | 86.89B | 29.93 | 21.25 | 16.57 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Sun Pharma | INE044A01036 | 12.99 | 1,795.30 | +0.86% | |
Max Healthcare Institute | INE027H01010 | 6.26 | 999.95 | +0.99% | |
Divi's Labs | INE361B01024 | 6.21 | 5,998.35 | +0.36% | |
Poly Medicure Ltd | INE205C01021 | 5.38 | 2,582.15 | -0.27% | |
Lupin | INE326A01037 | 5.12 | 2,071.35 | +1.39% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Sell | Strong Buy | BUY |
Summary | Neutral | Strong Buy | Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review